TP53 mutations predict poor breast cancer–specific survival in ER-positive breast cancer patients
- DOI
- 10.1016/j.canep.2026.103204
- Published
- 2026-10
- Container
- Cancer Epidemiology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.canep.2026.103204,
title = {TP53 mutations predict poor breast cancer–specific survival in ER-positive breast cancer patients},
author = {S. Ragnarsdottir and E.A. Frick and O.A. Stefansson and T. Gudjonsson and L. Tryggvadottir and T. Aspelund and O. Bjarnadottir and L. Vidarsdottir and S. Sigurdsson},
year = {2026},
journal = {Cancer Epidemiology},
doi = {10.1016/j.canep.2026.103204},
url = {https://doi.org/10.1016/j.canep.2026.103204}
}RIS
TY - JOUR TI - TP53 mutations predict poor breast cancer–specific survival in ER-positive breast cancer patients AU - S. Ragnarsdottir AU - E.A. Frick AU - O.A. Stefansson AU - T. Gudjonsson AU - L. Tryggvadottir AU - T. Aspelund AU - O. Bjarnadottir AU - L. Vidarsdottir AU - S. Sigurdsson PY - 2026 JO - Cancer Epidemiology DO - 10.1016/j.canep.2026.103204 UR - https://doi.org/10.1016/j.canep.2026.103204 ER -
APA
Ragnarsdottir, S., Frick, E., Stefansson, O., Gudjonsson, T., Tryggvadottir, L., Aspelund, T., Bjarnadottir, O., Vidarsdottir, L., & Sigurdsson, S. (2026). TP53 mutations predict poor breast cancer–specific survival in ER-positive breast cancer patients. Cancer Epidemiology. https://doi.org/10.1016/j.canep.2026.103204
Source records
- crossref · retrieved 2026-09-25T15:10:28.016Z